Steffen Flindt Nielsen

5PUBLICATIONS
6CO-AUTHORS
Public health nutritionFood properties (incl. characteristics and health benefits)Gene expression (incl. microarray and other genome-wide approaches)Systems physiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 04, 2025
Sodium reduction is the key ingredient in dietary treatment of hypertension - a randomized controlled trial on sodium, potassium and nitrate.

Camilla L Duus, Steffen F Nielsen, Trine Z Lyksholm

|Sep 25, 2025
Empagliflozin and fluid balance: results from the SiRENA project.

Steffen Flindt Nielsen, Camilla Lundgreen Duus, Niels Henrik Buus

|Jul 28, 2025
The Effect of SGLT2 Inhibitors on Blood Pressure in Relation to Baseline Kidney Function: A Systematic Literature Review and Data Analysis.

Charlotte Agergaard Møller, Steffen Flindt Nielsen, Frank Holden Mose

|Jun 06, 2024
Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial.

Camilla Lundgreen Duus, Steffen Flindt Nielsen, Bodil Gade Hornstrup

|Apr 29, 2024
Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project).

Steffen Flindt Nielsen, Camilla Lundgreen Duus, Niels Henrik Buus

Pageof 1

Frequent Collaborators

4 joint publications

Frank Holden Mose

3 joint publications

Camilla Lundgreen Duus

2 joint publications

Niels Henrik Buus

2 joint publications

Jesper Nørgaard Bech